statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	1.195
RU - Federazione Russa	276
IT - Italia	207
SG - Singapore	149
CN - Cina	113
HK - Hong Kong	61
IE - Irlanda	57
VN - Vietnam	49
SE - Svezia	42
BR - Brasile	41
KR - Corea	39
DE - Germania	35
FR - Francia	30
PL - Polonia	29
BD - Bangladesh	22
FI - Finlandia	22
IN - India	20
TW - Taiwan	17
GB - Regno Unito	12
CA - Canada	11
JP - Giappone	9
AU - Australia	8
ID - Indonesia	8
JO - Giordania	8
PK - Pakistan	8
BE - Belgio	5
NL - Olanda	5
CI - Costa d'Avorio	4
TN - Tunisia	4
TR - Turchia	4
UA - Ucraina	4
DZ - Algeria	3
ES - Italia	3
LV - Lettonia	3
ZA - Sudafrica	3
AM - Armenia	2
AR - Argentina	2
BO - Bolivia	2
EC - Ecuador	2
IQ - Iraq	2
OM - Oman	2
PH - Filippine	2
AE - Emirati Arabi Uniti	1
AT - Austria	1
BG - Bulgaria	1
BY - Bielorussia	1
ET - Etiopia	1
GE - Georgia	1
HR - Croazia	1
JM - Giamaica	1
LA - Repubblica Popolare Democratica del Laos	1
LK - Sri Lanka	1
LY - Libia	1
MM - Myanmar	1
MX - Messico	1
MY - Malesia	1
NO - Norvegia	1
PR - Porto Rico	1
PY - Paraguay	1
RO - Romania	1
SA - Arabia Saudita	1
VE - Venezuela	1
Totale	2.540

Nome	#
New therapeutic strategies for the treatment of inflammatory diseases	273
Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors	223
Synthesis of New GABAA Receptor Modulator with Pyrazolo[1,5-a]quinazoline (PQ) Scaffold	213
1H-pyrrolo[2,3-b]pyridine: a new scaffold for human neutrophil elastase (HNE) inhibitors	207
Further modifications of 1H-pyrrolo[2,3-b]pyridine derivatives as inhibitors of human neutrophil elastase	202
Exploration of Nitrogen Heterocycle Scaffolds for the Development of Potent Human Neutrophil Elastase Inhibitors	201
1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors	191
'Proximity frequencies' a new parameter to evaluate the profile of GABAAR modulators	166
Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonists	166
New 3-unsubstituted Isoxazolones as Potent Human Neutrophil Elastase Inhibitors: Synthesis and Molecular Dynamic Simulation	165
Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis	159
New 3,6-disubstituted pyrazolo[1,5-a]quinazolines as ligands to GABAA receptor subtype	152
Pyridazinones and Structurally Related Derivatives with Anti-Inflammatory Activity	138
Novel Sulfonamide Analogs of Sivelestat as Potent Human Neutrophil Elastase Inhibitors	132
Totale	2.588

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	16	0	0	0	0	0	0	0	0	0	0	0	16
2021/2022	139	4	1	25	4	6	13	2	16	5	9	25	29
2022/2023	268	24	79	15	15	4	41	36	18	19	1	13	3
2023/2024	134	7	11	18	4	6	12	7	37	5	18	7	2
2024/2025	856	41	108	56	112	225	92	31	34	48	28	35	46
2025/2026	810	81	96	49	40	98	24	104	39	70	60	54	95
Totale													2.588